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Abstract  
 
Background. The screening behaviour and screening outcomes of men ≥ 50 years was 
investigated within a randomized controlled trial of a community-based intervention of 
screening for melanoma, consisting of a community education program, an education 
program for medical practitioners and the provision of dedicated skin screening clinics.  
Methods. Data from cross-sectional telephone surveys before (559 completed 
interviews); at the end (591 completed interview); and at 2 year after the intervention 
(445 completed interviews) were analysed. In addition, we analysed data from skin 
screening clinics within the intervention program (3,355 men ≥ 50 years participated).  
Results. During the intervention period men ≥ 50 years  increased both their screening 
behaviour and intention to screen. Those men ≥ 50 years  who reported a past history of 
removal of a mole as well as other risk factors for skin cancer and positive attitudes 
towards screening were more likely to participate in skin screening across time. Men ≥ 
50 years accounted for 20.5% of all skin screening clinic attendees, 31.3% of those 
referred for a suspicious lesion, 48.5% of melanomas, and 45% of all Keratinocyte 
Carcinomas diagnosed within the screening program, respectively. 
Conclusions. The intervention program successfully motivated men ≥ 50 years  to attend 
screening for skin cancer, resulting in the highest yield of skin cancer within this 
subgroup of the population. Messages addressing skin cancer risk factors and attitudes 
towards skin cancer and screening could be used to target a screening program for 
melanoma towards men ≥ 50 years.
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Condensed abstract: Within a population based screening program for melanoma men ≥ 
50 years significantly increased their participation in screening for melanoma and 
intention to screen. Within skin screening clinics provided within the intervention 
program, men ≥ 50 years contributed 48.5% of melanomas, and 45% of all Keratinocyte 
Carcinomas diagnosed.   
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Excluding Keratinocyte Carcinoma (KC)(basal and squamous cell carcinoma), melanoma 
is the fourth most common cancer in Australia, with 8,885 new cases diagnosed in 
Australia in 2001 (population approximately 19,400,000) 1. In the US, where the 
incidence of melanoma is rising rapidly, 59,580 new cases of melanoma are expected for 
2005 (population approximately 294,000,000) 2. Men accounted for 56% of all new 
melanoma cases, and for 63% of all melanoma related deaths in both Australia and the 
US 1-3. Melanoma incidence continues to rise over-proportionally in men over 50 4. 
The thickness of the lesion at diagnosis is one of the most important prognostic indicators 
for survival from melanoma 5, 6 and diagnosis and treatment of melanomas while still thin 
is likely to improve survival from this disease 7, 8. Screening for melanoma has the 
potential to improve early diagnosis. Although there is at present no conclusive evidence 
that screening for melanoma will reduce morbidity and mortality from melanoma, the US 
Preventive Task Force (USPTF) describes screening as the most promising strategy 
especially for older people 9.  The American Cancer Society recommends a skin 
examination as a component of any routine cancer-related check-up 10.  Targeted 
screening towards those older than 50 years has been suggested as a possible way to 
increase its cost-effectiveness 11, 12. Previous studies found men ≥ 50 years more 
commonly present with thick and nodular melanomas compared to women and younger 
people, and should be targeted by early detection programs 4, 13-18. Despite this, within 
general practice, excisions are more commonly performed on patients younger than 50 
years compared to patients ≥ 50 years 19. Older men are also less likely to self-present 
with a lesion of concern at open access community screening programs 20. However, 
despite representing only 25% of all screenees, men over 50 contribute 44% of those with 
a confirmed melanoma within such clinics 21. Reduced ability to recognise a melanoma 
was reported for older compared to younger people, and older men frequently have 
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lesions in difficult to see areas such as the scalp and the back, and may therefore be 
additionally limited in their ability to notice any new or changing lesions themselves 15.  
 
The present investigation presents an important part of the first phase of a randomised 
controlled trial of a community based intervention of screening for melanoma 22, 23. 
Earlier we reported the results from the baseline survey of this trial. People ≥ 50 years 
were less likely to conduct a whole-body skin self-examination compared to younger 
people 24, but there was no difference between men and women or between different age 
groups with regards to self-reported prevalence of a whole-body skin examination by a 
general practitioner (clinical skin examination) within the past 12 months 25. Men were 
less likely to indicate an intention to conduct skin self-examination or to attend a doctor 
for a skin examination within the next 12 months than women suggesting that changing 
this behaviour in men could prove challenging. Although having had a previous clinical 
examination by a doctor was most strongly related to future screening intention, several 
attitudinal factors (perceived susceptibility, giving skin checks a high priority, previous 
history of NMSC) were also associated with intention to screen 26. 
After completion of the trial we investigated changes in skin screening behaviour over 
time in intervention and control communities. Overall, within the intervention 
communities, the prevalence of whole-body skin examinations increased from 11% at 
baseline to a maximum of 34.8% two years into the trial, while screening rates amongst 
control communities remained stable. Uptake was highest amongst the population ≥ 50 
years 27.  
 The present paper investigates predictors of skin screening participation of men ≥ 50 
years within the 3-year community based screening program for melanoma. We also 
describe the clinical and histopathological outcomes of screening examinations in men ≥ 
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50 years who attended one of the dedicated skin screening clinics provided during the 
intervention period.  
 
Materials and Methods 
The design, intervention and implementation of the intervention program has been 
described in detail elsewhere 22, 23. The aim of the trial was to determine the effectiveness 
of a community-based melanoma screening program in reducing melanoma mortality.  
The intervention consisted of three interrelated components: community education about 
early detection of skin cancer, education for local doctors in early detection of skin 
cancer and dedicated skin screening clinics. The objective was to increase to 60% the 
proportion of the population over 30 years within intervention communities who had at 
least one whole-body skin examination within the three year intervention period. During 
the first phase, eighteen Queensland communities each with an adult (≥ 30 years) 
population of ≥ 2,000 were enrolled, for a total adult population of 63,035. Nine 
intervention communities were randomly allocated to receive a three-year community-
based melanoma screening program, with the remaining nine control communities 
receiving standard practice only. The target population for screening was defined as those 
30 years and over as mortality from melanoma is rare under this age 1. For the purpose of 
this analysis, only data from the nine intervention communities were used.  
The respondents' self-reported skin screening behaviour, skin cancer risk factors and 
attitudes towards skin cancer and skin screening were monitored by cross-sectional 
telephone surveys at 3 time-points: baseline (4 weeks prior to the intervention program 
during 1998), 36-month follow-up (at the end of the intervention period during 2001) and 
5 year follow-up (2 years after the end of the intervention period during 2003) 27.  
 7
Telephone surveys 
Professional telephone interviewers used a Computer-Assisted Telephone Interview 
System (CATI) to reach random samples of community residents ≥ 30 years selected 
from a commercially available directory of telephone numbers (equal numbers of men 
and women were ascertained through a quota system). The response rate for the 1998 
survey was 66.9% (3,110 completed interviews); 66.5% for the 2001 survey (5,048 
completed interviews; and 65.1% in 2003 (3,514 completed interviews) (66.2% overall). 
Compared to the 1996 and 2001 Australian census, the sociodemographic characteristics 
of the survey respondents were similar with respect to sex, age, employment and marital 
status to the respective populations. For the purpose of this investigation only the data 
from men ≥ 50 years were utilized. 
Skin screening clinics  
During the intervention period, local doctors (in primary care practises) screened patients 
within their day to day practices and some also organised screening clinics within their 
private practices. In addition, centrally organised skin screening clinics staffed by local 
doctors and additional doctors hired from outside the communities were held in 
intervention communities. Overall, within those dedicated clinics, primary care 
physicians conducted 16,383 whole-body skin examinations. The aims, procedures and 
outcomes of the skin screening clinics have been described in detail elsewhere 27. 
Members of intervention communities were alerted to the clinics through advertisements 
and articles in local newspapers, street banners, flyers and information brochures in 
doctors practices and other places of interest, and personal letters of invitation signed by 
a sports celebrity for men and a media celebrity for women. The letters contained 
information about the time and place of the clinics and a toll free telephone number for 
appointments. Care was taken to test the design of the letters directed at men for their 
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suitability for this target group. The value of these letters for motivating men to attend 
screening with or without the addition of a glossy brochure was tested within a nested 
randomised trial at the beginning of the intervention period. There was no additional 
effect over and above the letter for the brochures and therefore the brochure was not used 
during subsequent invitations directed at men 28.  
Clinics were held in workplaces, community venues and local hospitals and participants 
completed a questionnaire before their examination which included demographic 
characteristics, history of skin screening and skin cancer risk factors.  Participants signed 
consent forms for the whole-body examination and to allow access to relevant medical 
information resulting from the skin examination. Overall, 2,302 (14.1%) clinic attendees 
were referred back to their own doctor for investigation of 4,129 suspicious lesions. The 
location and provisional diagnosis of the suspicious lesion discovered during the 
examination was noted by the skin clinic doctor on the referral form which was given to the 
patient. A copy was also retained by the research team. Of those referred, 1,822 (79.2%) 
filled their referral after a maximum of two telephone and written reminders. For these 
patients, their doctor recorded how the lesion was managed and the date of management. If 
a lesion was excised or biopsied, histopathology reports were obtained.  
Measures 
A detailed description of the telephone survey development and psychometric testing can be 
found elsewhere 25, 26. The following variables were measured during the telephone 
interviews and used for the present analysis:  
1) Sociodemographic factors – sex and age;  
2) Skin cancer risk factors – history of spot or mole removal; personal and family 
history of KC or melanoma;  
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3) Attitudes and intentions towards skin screening – intention to have a clinical skin 
examination within the next 12 months; intention to examine the own skin in the next 
12 months; perceived susceptibility to develop skin cancer; concern about skin 
cancer; current concern about a specific spot or mole;  
4) Past skin screening behaviour - skin screening by whole-body skin examination by a 
doctor during the past 12 months. 
 
Data analyses 
Changes in reported screening behaviour, attitudes and intentions towards skin cancer 
screening based on the telephone surveys were assessed using logistic regression models. 
Separate models were used for each outcome. A three-level categorical variable 
representing the survey period was the dependent variable, and baseline prevalence was 
taken as the reference point. The change in attitudes and behaviours over time was 
expressed as adjusted Odds Ratios (OR) and Confidence Intervals (CI). The significance 
of the overall change was assessed by the Wald chi-square statistic from the logistic 
model. To adjust for the cluster design of the study (with communities being the cluster 
unit), the logistic regression models were carried out using the statistical package 
SUDAAN 29, which allows for the increase in variation associated with this type of study 
design. 
We also fitted multivariate random effect models (using the glimmix macro in SAS (SAS 
Institute Inc., Cary, North Carolina 27513) to assess the influence of doctor 
recommendations or instructions to self-examine the skin, skin cancer risk factors and 
attitudes on skin screening participation throughout the trial period. Separate models 
were used for each factor, and included two way interaction terms between time and the 
specific factor. 
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Results 
Telephone survey results 
Within intervention communities, men ≥ 50 years were nearly four times more likely to 
report a clinical whole-body skin examination in the past 12 months at the end of the 
intervention (32.8%) compared to baseline (10.6%), and still more than twice as likely 
two years after completion of the intervention (24.8%). Men over 50 were twice as likely 
to report conducting a whole-body skin self-examination within the past 12 months at the 
end of the intervention (27.5%) and at 2 years follow-up (28.0%) compared to baseline 
(15.8%). Additionally, men ≥ 50 years were significantly more likely to report an 
intention to conduct skin self-examination at the end of the intervention (85.0%) and at 2 
year follow-up (81.2%) compared to baseline (60.8%) (Table 1). 
At the end of the intervention period (22.5%) and 2 year follow-up (24.2%) we found no 
increase in the proportion of men ≥ 50 years who indicated their doctor suggested they 
conduct a skin self-examination compared to baseline (23.4%). Somewhat more men 
indicated at later time-points (15.7% and 14.2% at end of intervention and 2 year follow-
up, respectively) that they received instructions by their doctor how to conduct a skin 
self-examination compared to baseline (9.6%), however, this did not reach significance 
as indicated by the CI‘s (Table 1). Similarly, the proportion of men who perceived 
themselves at high risk of skin cancer, reported a current concern about a spot or mole, 
were very concerned about skin cancer, or expressed the view that skin checks are a 
priority remained stable throughout the intervention period. Men ≥ 50 years reported a 
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significant reduction in confidence that they could find a suspicious spot or mole at the 
end of the intervention (79.4%) and at two years follow-up (72.5%) compared to baseline 
(85.9%). There was no significant change in participants’ attitude towards contacting a 
doctor if they detected something suspicious on their skin, or confidence in their doctor’s 
ability to diagnose skin cancer throughout the observation period. There was a slight 
decrease in the number of men over 50 reporting that they ever had a spot or mole 
removed in the past (baseline = 67.4%; end of intervention = 65.9%; 2 year follow-up= 
64.7%), or reporting a history of melanoma or KC compared to baseline (Table 1).    
The random effects models to explain the influence of skin cancer risk factors and 
attitudinal factors on participation in skin screening across all three time points revealed a 
significant interaction effect for the models ‘time’ x  ‘doctor taught how to perform a 
skin self-examination’ (F (2; 1394) = 6.52; p ≤ 0.001, ‘time’ x  ‘very likely to develop 
skin cancer’  (F(2;31565) = 9.77; p ≤ 0.001) and ‘time’ x  ‘confident that I could find a 
suspicious spot’ (F(2;1565) = 3.13; p =0.04) (Table 2). Generally the immediate effect of 
the intervention was to reduce the effect of these variables on the outcome measure. For 
example at baseline, nearly twice as many men who thought they were very likely to 
develop skin cancer reported to have recently received a whole-body skin examination 
(14%) compared to those who thought they were unlikely (8%). Following the 
intervention, the difference in reported whole-body skin examinations was reduced (34% 
to 32%). This reduction in these subgroup differences did not persist long term (ie. 2 
years after the intervention), particularly for ‘doctor taught skin examination” and a 
perception of increased personal risk of skin cancer. All other interactions were not 
significant indicating that men reporting these skin cancer risk factors or positive 
attitudes towards skin screening were consistently more likely to also report a whole-
body skin examination within the past 12 months across all three timepoints (Table 2). 
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Skin screening clinic outcomes for men ≥ 50 years 
Men ≥ 50 years comprised 22% of the population within intervention communities, 
20.5% of all those who attended the skin screening clinics provided as one component of 
the intervention program, however, this same group comprised 31.3% of those referred 
for a suspicious lesion. Of those men ≥ 50 years referred (n=720), 81.5% attended a 
doctor for their referral. Of all 1,343 lesions excised or biopsied, 31.3% were on men ≥ 
50 years, and, of lesions assumed to be melanoma, 32.7% were on men ≥ 50 years. Of 
the histologically confirmed melanomas, 48.5% were found within this same group. Of 
all BCC’s and SCC’s diagnosed within the screening program, 46.3% and 44.3% were 
found on men ≥ 50 years, respectively. 
The overall yield of melanoma in the screening program was 33/16,383 (2.0 per 1,000 
screenings), with a yield of 16/3,355 (4.8 per 1,000 screenings) in men ≥ 50 years 
compared with 17/13028 amongst all other participants (1.3 per 1,000 screenings). Of the 
16 melanomas detected in men ≥ 50 years, 50% were in-situ and 50% less than 1mm 
thick. The most common location of melanomas in men older than 50 years was on the 
back (69%). Of men ≥ 50 years who were diagnosed with melanoma during the screening 
program, all reported a past history of having a spot or mole removed, and 11 (68.8%) 
men were currently concerned about a spot or mole.  
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Discussion 
These results indicate that within a community based randomised screening program, 
men ≥ 50 years can be motivated to participate in screening for melanoma and that with 
screening examinations, melanomas are more commonly detected in men ≥ 50 years than 
other screening participants. Despite the fact that men at baseline indicated less intention 
to screen for melanoma compared to women 26, the community intervention program was 
successful in inducing behaviour change in men ≥ 50 years by  increasing their rate of 
whole-body clinical skin examinations by four-fold, and the rate of skin self-
examinations by two-fold. Also, their screening behaviour during the two years following 
the intervention declined more slowly compared to screening participants overall 27.  
The community based intervention program of melanoma screening employed within this 
randomized trial was not specifically targeted at men ≥ 50 years. However, particular 
care was taken to ensure it was also suitable to a male audience 23. All materials were 
written at primary school reading levels, and earlier we reported that residents of all 
educational levels were equally likely to attend the screening clinics 30. Skin screening 
clinics were advertised in local newspapers and all residents were sent letters of 
invitation which were thoroughly pilot tested 28.  Screening services were located in 
workplaces, hospitals and community centres to make them easily accessible for men. In 
addition, the educational package for medical practitioners included information on the 
disproportional risk of thick melanomas in men ≥ 50 years. All of these components may 
have contributed to the successful behavioural change observed amongst men ≥ 50 years 
within the present study.  
Across all time periods those men who reported risk factors such as the removal of a spot 
or mole in the past or current concern about a spot or mole of were consistently more 
likely to participate in screening compared to men ≥ 50 years without such a history, and 
 14
all men diagnosed with melanoma reported the removal of a spot or mole in the past. 
These results are similar to findings from the American Academy of Dermatology 
(AAD) National Skin Screening Program, resulting in the recommendation to focus 
screening towards men with a changing mole to further increase the yield of melanoma 
within the screened population 21. These results also support the notion that the natural 
increase in removal of benign lesions and KCs through a screening program for 
melanoma may positively influence screening participation during subsequent rounds by 
increasing awareness of the importance of skin checks 31. On the other hand, future 
screening programs will need to target those men ≥ 50 years who never had a spot or 
mole removed and who are unconcerned about a mole or spot to raise their attendance 
rates. 
The association of confidence to self-detect a spot and screening behaviour under the 
influence of the intervention program was somewhat different from the other attitudinal 
factors. Men who reported less confidence in their own ability to self-detect a spot or 
mole were more likely to report a skin examination at baseline and at the end of the 
intervention program, but fell below men with such confidence after the intervention 
ceased. Overall we observed that men’s confidence to self-detect a spot or mole of 
concern decreased significantly over time. This suggests addressing men’s confidence 
and self-detection skills could be important within skin screening promotion, possibly 
through increasing skin self-examination recommendations and instructions by general 
practitioners. Within the present screening program, we did not observe a significant 
increase in doctors recommending such skin self-examination behaviour, leaving quite a 
large leeway for improvement. In an innovative approach, which may be transferable to a 
population setting, high risk patients were provided with images of their body surface 
and instructions to systematically examine the skin of the whole body 32. This 
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intervention increased the median frequency of self-examination from twice yearly to six 
times yearly. More than 50% of participants used the images provided to assist their self-
examination 32, thus potentially increasing their confidence that they could detect any 
notable change. 
Men ≥ 50 years contributed 30% of the referred patients, and also 30% of the patients 
who received a biopsy or excision for a suspicious lesion. In addition, nearly 50% of the 
melanoma cases were detected on men ≥ 50 years. These figures are very similar to those 
reported by the AAD National Skin Screening program, where dermatologists screened 
more than 600,000 individuals over the past 15 years 20. Within this program, men ≥ 50 
years comprised 25% of all screening participants, but 44% of all confirmed melanoma 
cases. The yield per 1,000 screenings was higher amongst men over 50 within the present 
screening program (4.8) compared to the AAD program (2.6), highlighting the 
importance of screening efforts for men ≥ 50 years within Australian.  
Within this community screening program men over 50 also had the highest yield of 
KC’s and seborrhoeic keratoses. While the detection of KC’s is not the primary aim of 
the program, removal of a KC or even a benign lesion could increase the willingness of 
men over 50 to undergo further screening for melanoma through changes in perceived 
susceptibility 33. The time spent with the medical practitioner while undergoing an 
excision or biopsy may also provide an opportunity for health education in a teachable 
moment 24.  
The main health promotion messages of the community based intervention program 
encouraged attendance at a skin screening clinic for a whole-body screen by a doctor, but 
also encouraged participants to examine their own skin and present to a doctor with any 
suspicious lesion. In a case control study of melanoma in Connecticut skin awareness 
was associated with a favourable prognosis besides other, well known predictive factors 
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of melanoma outcome such as Breslow thickness and mitotic index 34. It has been 
suggested that men should be encouraged to note any change in size of a lesion and that 
this should trigger action even in the absence of other symptoms 16.   However in the 
present study, similar to previous observations, the majority of melanomas in these older 
men were located on the back – a difficult to see area 15. These findings also point 
towards the limits of part-body examinations and self-examinations if these are not 
conducted thoroughly, using a mirror or utilising the help of a second person to locate 
lesions on difficult to see areas 8.  
This randomised trial employed a nested cross sectional design to monitor uptake of 
screening. The advantage of using such design is that the results are not affected by 
cohort movements (in-migration and out-migration). However, this design does not allow 
statistical modelling of changes in behaviour and intentions to the same extend as a 
nested cohort design with longitudinal measurement 35. Although the yield of melanoma 
cases detected within the screening program was higher than reported from open skin 
screening days in the US or elsewhere 36, the number of melanomas detected is still 
small, and therefore results need to be interpreted with caution. The generalizability of 
these results may be limited as the study communities were located in rural and regional 
areas of Queensland. Although the participants had similar sociodemographic 
characteristics compared to the Australian census, they may have differed in some 
characteristics from those not participating in the surveys .  
Our results are the first to report on the screening behaviour and detection patterns 
amongst men ≥ 50 years within a population based screening program for melanoma. 
They provide evidence that the skin screening behaviour of this population subgroup is 
amenable to change through a community based intervention program. However, the 
ability to sustain high levels of screening activity will depend on the availability of 
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services. Future population based melanoma screening programs need to emphasize the 
importance of whole-body examinations both by patients themselves and their doctors. 
Our results also suggest that to sustain screening rates in men ≥ 50 years an  
understanding of their susceptibility to melanoma and their doctor’s encouragement of 
early detection and screening behaviour will be important.   
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Table 1:  Changes in screening behaviour, attitudes and intentions towards skin cancer 
from baseline to the end of the intervention and 2 years after the intervention amongst 
men 50 (Intervention communities only)* 
  Odds Ratio (95% CI)a   
  Baseline 
Surveyc  
(n = 559) 
 Survey - End of 
interventionc 
(n = 591) 
 Survey - 2 year 
follow-upc 
(n = 445) 
 Wald F; p 
value 
       
Had a clinical  whole-body skin 
examination in the past 12 months    
 1.00  4.12 (2.62-6.47)  2.78 (1.73-4.47)  19.6; <0.001 
Has performed whole-body skin self-
examination within the past 12 
months 
 1.00  2.01 (1.29-3.14)  2.06 (1.31-3.26)  5.30; 0.005 
Intend to have a clinical skin 
examination within the next 12 
months  
 1.00  1.13 (0.74-1.72)  1.03 (0.67-1.58)  0.33; 0.72 
Intend to check my own skin in the 
next 12 months  
 1.00  2.14 (1.30-3.53)  1.62 (0.98-2.69)  4.74; <0.001 
Doctor suggested to perform skin self-
examination within the past 12 
months 
 1.00  0.95 (0.52-1.72)  1.04 (0.57-1.91)  0.17; 0.85 
Doctor taught how to perform skin 
self-examination within the past 12 
months 
 1.00  1.74 (0.98-3.08)  1.54 (0.86-2.78)  1.81; 0.16 
Very likely to develop skin cancer  1.00  0.60 (0.39-0.92)  0.67 (0.43-1.04)  2.69; 0.07 
Current concern about a spot or mole     1.00  0.98 (0.59-1.63)  0.70 (0.41-1.20)  2.10; 0.12 
Very concerned about skin cancer    1.00  0.78 (0.50-1.23)  0.73 (0.45-1.16)  0.89; 0.41 
Regular skin checks are a priority           1.00  0.84 (0.53-1.33)  0.74 (0.46-1.20)  0.89; 0.41 
Confident that I could find a 
suspicious spot or mole 
 1.00  0.63 (0.38-1.06)  0.43 (0.25-0.73)  6.08; 0.002 
I would contact the doctor 
immediately if I found something 
suspicious 
 1.00  1.43 (0.86-2.39)  1.42 (0.83-2.41)  1.00; 0.37 
Confident that doctor can diagnose 
skin cancer 
 1.00  0.96 (0.55-1.66)  1.01 (0.57-1.77)  0.04; 0.95 
Ever had a spot or mole removed            1.00  0.94 (0.60-1.46)  0.89 (0.56-1.40)  0.16; 0.85 
History of melanoma   1.00  1.07 (0.54-2.12)  1.46 (0.72-2.93)  0.99; 0.37 
History of KC b  1.00  1.30 (0.74-2.30)  1.49 (0.83-2.67)  1.00; 0.37 
a Odds Ratio (95% confidence intervals) calculated by logistic regression models using SUDAAN adjusted 
for cluster sampling using the baseline survey as the reference category.  
b  Keratinocyte Carcinoma (KC) (basal and squamous cell carcinoma). 
c  Cross sectional survey at each time point 
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Table 2: Influence of attitudes, skin cancer risk factors and doctors recommendation of 
skin self-examination on whole-body skin examinations  
 
  % (n)  reporting a whole-body skin examination within the 
past 12 months 
  
  Baseline 
Survey b  
(n = 559)  
 Survey  End of 
intervention b 
(n = 591) 
 Survey 2 year 
follow-up b 
(n = 445) 
 F-Value 
(interaction); 
p-value 
Doctor suggested to perform skin 
self-examination within the past 12 
months 
Y 
N 
31.2 (36) 
6.3 (39) 
 58.0 (68) 
23.7 (96) 
 53.4 (49) 
13.7 (41) 
 1.97, 0.14 
Doctor taught how to perform skin 
self-examination within the past 12 
months 
Y 
N 
66.1 (24) 
5.19 (51) 
 66.3 (51) 
24.8 (113) 
 60.9 (35) 
16.6 (56) 
 6.52, 0.001 
Very likely to develop skin cancer Y 
N 
14.1 (33) 
8.1 (44) 
 34.1 (61) 
32.0 (135) 
 41.7 (61) 
16.7 (48) 
 9.77, <0.001 
Current concern about a spot or 
mole    
Y 
N 
13.4 (20) 
9.9 (57) 
 28.3 (35) 
33.7 (161) 
 31.2 (22) 
23.6 (87) 
 2.07, 0.13 
Very concerned about skin cancer   Y 
N 
15.7 (38) 
9.9 (57) 
 28.3 (35) 
33.7 (161) 
 31.2 (22) 
23.6 (87) 
 1.98, 0.14 
Regular skin checks are a priority     Y 
N 
14.9 (68) 
3.9 (9) 
 40.2 (136) 
22.7 (59) 
 31.2 (73) 
17.4 (36) 
 0.89, 0.41 
Confident that I could find a 
suspicious spot or mole 
Y 
N 
9.8 (65) 
15.6 (12) 
 31.3 (147) 
37.7 (49) 
 26.6 (84) 
19.9 (25) 
 3.13, 0.04 
I would contact the doctor 
immediately if I found something 
suspicious 
Y 
N 
13.3 (74) 
1.11 (3) 
 35.9 (180) 
16.1 (16) 
 26.8 (84) 
14.7 (11) 
 1.58, 0.21 
Confident that doctor can diagnose 
skin cancer 
Y 
N 
11.5 (70) 
6.2 (7) 
 33.5 (165) 
28.4 (31) 
 25.6 (95) 
20.5 (14) 
 0.53, 0.59 
Ever had a spot or mole removed      Y 
N 
10.5 (61) 
10.9 (16) 
 37.7 (145) 
24.2 (51) 
 28.5 (86) 
17.9 (23) 
 0.57, 0.55 
History of melanoma Y 
N 
20.3 (9) 
10.0 (68) 
 48.6 (20) 
31.5 (176) 
 41.2 (16) 
23.2 (93) 
 0.31, 0.73 
History of KC a Y 
N 
19.8 (12) 
7.6 (33) 
 44.3 (49) 
30.1 (147) 
 39.5 (37) 
21.0 (72) 
 0.57, 0.57 
Abbreviations: Y = Yes; N = No 
a  KC = Keratinocyte Carcinoma (basal and squamous cell carcinoma) 
b Cross sectional surveys at each time point 
 
